Clinical Trial Update: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30) [NA]

View source ↗

Summary

This clinical trial update covers GETUG-AFU 30, a study on adjuvant radiotherapy for patients with pathological high-risk muscle-invasive bladder cancer, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Snippet

Sponsor: UNICANCER | Conditions: Patients With High-risk MIBC | NA | Status: ACTIVE_NOT_RECRUITING